What's new

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised

Feb 27, 2025 - 09:56
 0
Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, ...

Next Article

Nicole Arbour: The Digital Superstar Dominating Entertainment with The Arbour Af...

Related Posts

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 1 April 2025 to 2 April 2025

European Medicines Agency (EMA) Patients' and Consumers...

Feb 17, 2025  0

Fees payable to the European Medicines Agency: Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices

Fees payable to the European Medicines Agency: Other fe...

Apr 15, 2025  0

Quetiapine

Quetiapine

Mar 11, 2025  0